Clinical Drug Experience Knowledgebase

Parkinson Disease

Acute Coronary Syndrome (Phase 4)

Acute Kidney Injury (Phase 3)

Aggression (Phase 2)

Alzheimer Disease (Phase 2)

Amyotrophic Lateral Sclerosis (Phase 3)

Aneurysm (Phase 2)

Ankle Injuries (Phase 3)

Asthma (Phase 1)

Brain Injuries (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Cardiac Output, Low (Phase 3)

Cardiovascular Diseases (Phase 4)

Central Nervous System Diseases (Phase 1)

Cerebral Infarction (Phase 2)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Constipation (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Drug Hypersensitivity (Phase 3)

Heart Diseases (Phase 2)

Heart Failure (Phase 4)

Hemorrhage (Phase 2)

Hepatic Insufficiency (Phase 1)

Hip Fractures (Phase 4)

Hypersensitivity (Phase 3)

Infarction (Phase 4)

Inflammation (Phase 4)

Ischemia (Phase 2)

Ischemic Attack, Transient (Phase 2)

Liver Failure (Phase 1)

Lung Neoplasms (Phase 3)

Malnutrition (Phase 1)

Motor Neuron Disease (Phase 3)

Muscle Weakness (Phase 3)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Neoplasms (Phase 2)

Parkinson Disease (Phase 4)

Prostatic Neoplasms (Phase 3)

Raynaud Disease (Phase 2)

Renal Insufficiency (Phase 1)

Respiratory Insufficiency (Phase 3)

Sclerosis (Phase 2)

Spondylarthritis (Phase 4)

Spondylarthropathies (Phase 4)

Spondylitis (Phase 4)

Spondylitis, Ankylosing (Phase 4)

Stroke (Phase 2)

Subarachnoid Hemorrhage (Phase 2)

Ulcer (Phase 2)

Wounds and Injuries (Phase 3)